Bio-Path Holdings, Inc

(NASDAQ:BPTH)

Latest On Bio-Path Holdings, Inc (BPTH):

Date/Time Type Description Signal Details
2023-05-12 21:27 ESTNewsBio-Path Holdings, Inc. (BPTH) Q1 2023 Earnings Call TranscriptN/A
2023-05-12 07:11 ESTNewsBio-Path GAAP EPS of -$0.66 misses by $0.34N/A
2023-03-31 18:11 ESTNewsBio-Path GAAP EPS of -$1.91 misses by $1.46N/A
2023-03-31 18:11 ESTNewsBio-Path Holdings Inc. (BPTH) Q4 2022 Earnings Call TranscriptN/A
2022-11-15 16:27 ESTNewsBio-Path GAAP EPS of -$0.49 misses by $0.03N/A
2022-11-15 16:27 ESTNewsBio-Path Holdings Inc. (BPTH) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 16:12 ESTNewsBio-Path launches $2M stock offeringN/A
2022-08-16 22:27 ESTNewsBio-Path GAAP EPS of -$0.42 beats by $0.07N/A
2022-08-16 22:26 ESTNewsBio-Path Holdings Inc.'s (BPTH) CEO Peter Nielsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-05-18 04:11 ESTNewsBio-Path GAAP EPS of -$0.47 misses by $0.01N/A
2022-05-18 04:11 ESTNewsBio Path Holdings Inc. (BPTH) CEO Peter Nielsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-13 00:35 ESTNewsBio-Path Holdings gains on presentation of preclinical data for its product BP1003N/A
2022-03-12 03:18 ESTNewsBio-Path Holdings Inc. (BPTH) CEO Peter Nielsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-11 08:26 ESTNewsBio-Path GAAP EPS of -$1.55 misses by $0.27N/A
2021-12-13 16:40 ESTNewsBio-Path presents data from Phase 2 prexigebersen study in AML at ASH 2021N/A
2021-11-12 18:06 ESTNewsBio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-27 14:59 ESTNewsBio-Path shares rise 10% after FDA greenlight for early-stage prexigebersen-A cancer trialN/A
2021-08-24 19:02 ESTNewsBio-Path gains a third on FDA clearance of BP1002 application in acute myeloid leukemiaN/A
2021-08-14 06:47 ESTNewsBio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-13 10:15 ESTNewsBio-Path EPS beats by $0.18N/A
2021-08-12 13:47 ESTNewsBio-Path Q2 2021 Earnings PreviewN/A
2021-07-20 22:49 ESTNewsBio-Path granted mechanism of action U.S. patent for BP1003N/A
2021-04-06 00:11 ESTNewsBio-Path shares rise after mid-stage leukemia trial updateN/A
2021-04-06 00:11 ESTNewsTSLA, NVTA, CHPT and NNOX among premarket gainersN/A
2021-03-12 21:41 ESTNewsBio-Path Holdings, Inc.'s (BPTH) CEO Peter Nielsen on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-12 07:16 ESTEarnings EstimateAn EPS average of -$1.97 is estimated for the 2022 year.Sell
2021-03-12 07:16 ESTAnalyst RatingThe Analyst Target Price has increased from $10 to $11.5.Buy
2021-03-11 04:06 ESTNewsBio-Path Holdings, Inc (BPTH) CEO Peter Nielsen on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-11 03:16 ESTEarnings EstimateAn EPS average of -$0.58 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-10 11:12 ESTFinancialsCompany financials have been released.Neutral
2021-03-10 08:49 ESTNewsBio-Path EPS beats by $0.21N/A
2021-02-17 00:42 ESTNewsBio-Path slips 8% on capital raiseN/A
2021-02-11 04:08 ESTNewsBio-Path stock soars on U.S. patent grantN/A
2021-01-02 15:17 ESTFinancialsCompany financials have been released.Neutral
2020-12-13 03:23 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 13:05 ESTNewsDosing underway in Bio-Path's early-stage BP1002 studyN/A
2020-11-18 03:18 ESTAnalyst RatingThe Analyst Target Price has decreased from $12 to $10.Neutral
2020-11-17 03:21 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 22:55 ESTNewsBio-Path EPS beats by $0.07N/A
2020-11-13 22:54 ESTNewsBio-Path Holdings' (BPTH) CEO Peter Nielsen on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-13 03:28 ESTEarnings EstimateAn EPS average of -$0.84 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-01 17:22 ESTFinancialsCompany financials have been released.Neutral
2020-10-22 18:25 ESTNewsU.S. patent covering prexigebersen lifts Bio-PathN/A
2020-09-24 00:17 ESTFinancialsCompany financials have been released.Neutral
2020-09-02 00:17 ESTFinancialsCompany financials have been released.Neutral
2020-08-18 04:16 ESTAnalyst RatingThe Analyst Target Price has decreased from $18 to $12.Neutral
2020-08-16 17:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 14:43 ESTNewsBio-Path EPS beats by $0.41N/A
2020-08-14 14:42 ESTNewsBio-Path Holdings Inc (BPTH) CEO Peter Nielsen on Q2 2020 Results - Earnings Call TranscriptN/A

About Bio-Path Holdings, Inc (BPTH):

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. The company is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

BPTH Quotes by TradingView

See Advanced Chart

General

  • Name Bio-Path Holdings, Inc
  • Symbol BPTH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 10
  • Last Split Factor1:20
  • Last Split Date2019-01-18
  • Fiscal Year EndDecember
  • IPO Date2008-03-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.biopathholdings.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 3.41
  • Enterprise Value EBITDA 0.22
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.98
  • Next Year EPS Estimate -$1.97
  • Next Quarter EPS Estimate -$0.75
  • Return on Assets -35%
  • Return on Equity -60%
  • Earnings Per Share -$6.19
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 49.26 million
  • EBITDA -8080000
  • Analyst Target Price $11.5
  • Book Value Per Share $3.32
View More

Share Statistics

  • Shares Outstanding 6.95 million
  • Shares Float 6.9 million
  • % Held by Insiders 102%
  • % Held by Institutions 7.77%
  • Shares Short 111802
  • Shares Short Prior Month 474210
  • Short Ratio 0.02
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 2.21
  • 52 Week High $9.4
  • 52 Week Low $3.12
  • 50 Day Moving Average 6.52
  • 200 Day Moving Average 4.54
View More

Dividends

  • Dividend Date 2019-01-18
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Bio-Path Holdings, Inc (BPTH) Dividend Calendar:

BPTH's last dividend payment was made to shareholders on January 18, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Bio-Path Holdings, Inc (BPTH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$0.57-$0.7826.92%
2020-09-302020-11-12$N/A-$0.80-$0.833.61%
2020-06-302020-08-13$N/A-$0.55-$0.8938.2%
2020-03-312020-05-14$N/A-$0.90-$0.67-34.33%
2019-12-312020-03-05$N/A-$0.73-$0.69-5.8%
2019-09-302019-11-14$N/A-$0.78-$0.74-5.41%
2019-06-302019-08-14$N/A-$0.87-$0.60-45%
2019-03-312019-05-15$N/A-$0.89
2018-12-312019-03-19$N/A-$2.81-$4.0029.83%
2018-09-302018-11-14$N/A-$5.37-$4.00-34.32%
2018-06-302018-08-14$N/A-$2.96-$4.0026.07%
2018-03-312018-04-02$N/A-$3.38-$4.0015.53%
2017-12-312018-03-16$37000-$4.00-$0.20-1900%
2017-09-302017-11-09$N/A-$4.00-$4.000%
2017-06-302017-08-09$N/A-$6.00-$4.00-50%
2017-03-312017-05-10$N/A-$2.00-$4.0050%
2016-12-312017-03-15$13000-$2.00-$5.0060%
2016-09-302016-11-09$N/A-$4.00-$4.000%
2016-06-302016-08-09$N/A-$4.00-$4.000%
2016-03-312016-05-10$N/A-$4.00-$4.000%
2015-12-312016-03-15$N/A-$2.00-$2.000%
2015-09-302015-11-09$N/A-$0.02-$0.01-100%
2015-06-302015-08-11$N/A-$0.01-$0.0366.67%
2015-03-312015-05-11$N/A-$0.02-$0.0333.33%
2014-12-312015-03-17$N/A-$0.02-$0.01-100%
2014-09-302014-11-14$N/A-$0.01-$0.010%
2014-06-302014-08-14$N/A-$2.00-$2.000%
2014-03-312014-05-15$N/A-$1.13
2013-09-302013-11-15$N/A-$3.70
2013-06-302013-08-15$N/A-$1.28
2013-03-312013-05-16$N/A-$2.11
2012-09-302012-11-16$N/A-$2.85
2012-06-302012-08-14$N/A-$2.68
2012-03-312012-05-30$N/A-$1.79
2011-09-302011-11-15$N/A-$1.79
2011-06-302011-08-15$N/A-$1.79
2011-03-312011-05-16-$2.00-$4.0050%
2010-12-312011-03-31-$2.00-$2.000%
2010-09-302010-11-15-$2.04
2010-06-302010-08-17-$1.79
2010-03-312010-06-02-$2.11
2009-12-312010-03-03-$2.00
2009-09-302009-12-02-$1.91
2009-06-302009-09-02-$2.53
2009-03-312009-06-03-$2.85
2008-12-312009-02-25-$9.19
2008-09-302008-11-14-$2.00-$4.0050%
2007-12-312007-12-31-$15.56
2007-09-302007-09-30-$1.72
2007-03-312007-03-31$3.21
2006-12-312006-12-31-$2.41
2006-09-302006-09-30-$2.42
2006-06-302006-06-30-$8.00
2006-03-312006-03-31-$2.26

Bio-Path Holdings, Inc (BPTH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Bio-Path Holdings, Inc (BPTH) Chart:

Bio-Path Holdings, Inc (BPTH) News:

Below you will find a list of latest news for Bio-Path Holdings, Inc (BPTH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Bio-Path Holdings, Inc (BPTH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest BPTH Trades:

Date Shares Price
Jun 13, 2022 6:13 PM EST100$3.38
Jun 13, 2022 6:13 PM EST300$3.38

Bio-Path Holdings, Inc (BPTH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000144495420000005/0001444954-20-000005-index.htm
2019-02-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133818/000000000019001678/0000000000-19-001678-index.htm
2019-05-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1133818/000000000019008756/0000000000-19-008756-index.htm
2019-01-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000090266419000402/0000902664-19-000402-index.htm
2020-01-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000090266420000225/0000902664-20-000225-index.htm
2019-01-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000091957419000547/0000919574-19-000547-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000091957419000549/0000919574-19-000549-index.htm
2019-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000091957419000645/0000919574-19-000645-index.htm
2019-11-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000091957419007520/0000919574-19-007520-index.htm
2019-03-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000100738219000001/0001007382-19-000001-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000100738219000002/0001007382-19-000002-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000100738219000003/0001007382-19-000003-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000100738219000004/0001007382-19-000004-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000100738219000005/0001007382-19-000005-index.htm
2019-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465919054163/0001104659-19-054163-index.htm
2019-11-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133818/000110465919059012/0001104659-19-059012-index.htm
2019-11-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1133818/000110465919059017/0001104659-19-059017-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000110465919064226/0001104659-19-064226-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465919064518/0001104659-19-064518-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465919066055/0001104659-19-066055-index.htm
2019-11-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000110465919066708/0001104659-19-066708-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465919066713/0001104659-19-066713-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465919067635/0001104659-19-067635-index.htm
2019-12-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000110465919068813/0001104659-19-068813-index.htm
2019-12-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465919075627/0001104659-19-075627-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920002278/0001104659-20-002278-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000110465920013402/0001104659-20-013402-index.htm
2020-02-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1133818/000110465920019245/0001104659-20-019245-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133818/000110465920029711/0001104659-20-029711-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920029894/0001104659-20-029894-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920031432/0001104659-20-031432-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920046014/0001104659-20-046014-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920051626/0001104659-20-051626-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000110465920061598/0001104659-20-061598-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920061647/0001104659-20-061647-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920062050/0001104659-20-062050-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920067765/0001104659-20-067765-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920081261/0001104659-20-081261-index.htm
2020-07-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000110465920083219/0001104659-20-083219-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920083224/0001104659-20-083224-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000110465920094673/0001104659-20-094673-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920094715/0001104659-20-094715-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920095009/0001104659-20-095009-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920103947/0001104659-20-103947-index.htm
2020-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000110465920117166/0001104659-20-117166-index.htm
2020-11-05DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133818/000110465920121811/0001104659-20-121811-index.htm
2020-11-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1133818/000110465920121821/0001104659-20-121821-index.htm
2018-04-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418021253/0001144204-18-021253-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418027188/0001144204-18-027188-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000114420418028882/0001144204-18-028882-index.htm
2018-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418029065/0001144204-18-029065-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000114420418044625/0001144204-18-044625-index.htm
2018-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418044826/0001144204-18-044826-index.htm
2018-08-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418045090/0001144204-18-045090-index.htm
2018-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418046528/0001144204-18-046528-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418047076/0001144204-18-047076-index.htm
2018-09-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000114420418050409/0001144204-18-050409-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418050410/0001144204-18-050410-index.htm
2018-10-23PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1133818/000114420418054944/0001144204-18-054944-index.htm
2018-11-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1133818/000114420418057055/0001144204-18-057055-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418057071/0001144204-18-057071-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000114420418059966/0001144204-18-059966-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418060142/0001144204-18-060142-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418062890/0001144204-18-062890-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418066055/0001144204-18-066055-index.htm
2018-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420418066409/0001144204-18-066409-index.htm
2018-12-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133818/000114420418066419/0001144204-18-066419-index.htm
2018-12-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133818/000114420418066422/0001144204-18-066422-index.htm
2019-01-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419001575/0001144204-19-001575-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419001576/0001144204-19-001576-index.htm
2019-01-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419001868/0001144204-19-001868-index.htm
2019-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419001872/0001144204-19-001872-index.htm
2019-01-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419002288/0001144204-19-002288-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419002290/0001144204-19-002290-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419005035/0001144204-19-005035-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419011177/0001144204-19-011177-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419012556/0001144204-19-012556-index.htm
2019-03-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419013719/0001144204-19-013719-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419013721/0001144204-19-013721-index.htm
2019-03-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1133818/000114420419014855/0001144204-19-014855-index.htm
2019-03-19S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133818/000114420419014867/0001144204-19-014867-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419014987/0001144204-19-014987-index.htm
2019-03-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133818/000114420419015105/0001144204-19-015105-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419018015/0001144204-19-018015-index.htm
2019-04-12RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419019543/0001144204-19-019543-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419026590/0001144204-19-026590-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419026726/0001144204-19-026726-index.htm
2019-05-16S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1133818/000114420419026840/0001144204-19-026840-index.htm
2019-06-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1133818/000114420419029625/0001144204-19-029625-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419029728/0001144204-19-029728-index.htm
2019-06-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419030111/0001144204-19-030111-index.htm
2019-06-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419030112/0001144204-19-030112-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1133818/000114420419040080/0001144204-19-040080-index.htm
2019-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419040193/0001144204-19-040193-index.htm
2019-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419041711/0001144204-19-041711-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419043406/0001144204-19-043406-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1133818/000114420419045944/0001144204-19-045944-index.htm
2019-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000119312519027018/0001193125-19-027018-index.htm
2019-03-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000119312519076310/0001193125-19-076310-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000119312520038498/0001193125-20-038498-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000119380520000214/0001193805-20-000214-index.htm
2019-12-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000121390019025109/0001213900-19-025109-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000144495420000001/0001444954-20-000001-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000144495420000002/0001444954-20-000002-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000144495420000003/0001444954-20-000003-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000144495420000004/0001444954-20-000004-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000144495420000005/0001444954-20-000005-index.htm
2018-09-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000153561018000099/0001535610-18-000099-index.htm
2019-01-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000153561019000042/0001535610-19-000042-index.htm
2019-03-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000153561019000072/0001535610-19-000072-index.htm
2020-01-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1133818/000153561020000011/0001535610-20-000011-index.htm
2018-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976518000001/0001599765-18-000001-index.htm
2018-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976518000002/0001599765-18-000002-index.htm
2018-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976518000003/0001599765-18-000003-index.htm
2018-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976518000004/0001599765-18-000004-index.htm
2018-10-05DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976518000005/0001599765-18-000005-index.htm
2019-01-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976519000001/0001599765-19-000001-index.htm
2019-01-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976519000002/0001599765-19-000002-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000159976519000003/0001599765-19-000003-index.htm
2019-10-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000179192619000001/0001791926-19-000001-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1133818/000179192620000001/0001791926-20-000001-index.htm
2019-03-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133818/999999999519000498/9999999995-19-000498-index.htm
2019-06-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1133818/999999999519001274/9999999995-19-001274-index.htm

Bio-Path Holdings, Inc (BPTH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bio-Path Holdings, Inc (BPTH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 102%
Institutional Ownership: 777%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-01-18ARMISTICE CAPITAL, LLC10% Share HolderSell0.00129,298.00https://www.sec.gov/Archives/edgar/data/1133818/000091957419000549/0000919574-19-000549-index.htm
2019-01-18ARMISTICE CAPITAL, LLC10% Share HolderSell64,457.002.66171,642.55129,298.00https://www.sec.gov/Archives/edgar/data/1133818/000091957419000549/0000919574-19-000549-index.htm